US2005261451A1PendingUtilityA1
Latent, high-activity olefin metathesis catalysts containing an N-heterocyclic carbene ligand
Est. expiryMar 29, 2024(expired)· nominal 20-yr term from priority
C07D 493/10C08F 132/08C07C 67/333C08G 2261/418C08G 2261/3325C07F 15/0046C08G 61/06C08G 61/02C08G 2261/11
56
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention provides novel organometallic complexes useful as olefin metathesis catalysts. The complexes have an N-heterocyclic carbene ligand and a chelating carbene ligand associated with a Group 8 transition metal center. The molecular structure of the complexes can be altered so as to provide a substantial latency period. The complexes are particularly useful in catalyzing ring closing metathesis of acyclic olefins and ring opening metathesis polymerization of cyclic olefins.
Claims
exact text as granted — not AI-modified1 . An organometallic complex comprising a Group 8 transition metal having an N-heterocyclic carbene ligand and an alkylidene group contained within a cyclic structure, wherein the complex is capable of catalyzing an olefin metathesis reaction with a latency period of at least two minutes.
2 . The organometallic complex of claim 1 , capable of catalyzing an olefin metathesis reaction with a latency period of at least five minutes.
3 . The organometallic complex of claim 1 , wherein the olefin metathesis reaction is ring closing metathesis.
4 . The organometallic complex of claim 1 , wherein the olefin metathesis reaction is ring opening metathesis polymerization.
5 . The organometallic complex of claim 2 , wherein the olefin metathesis reaction is ring closing metathesis.
6 . The organometallic complex of claim 2 , wherein the olefin metathesis reaction is ring opening metathesis polymerization.
7 . A complex having the structure of formula (I)
wherein:
α and β represent single bonds or unsaturated bonds, with the proviso that α and β cannot both be unsaturated bonds;
M is a Group 8 transition metal;
R 1 and R 2 are independently selected from hydrogen, hydrocarbyl, substituted hydrocarbyl, heteroatom-containing hydrocarbyl, substituted heteroatom-containing hydrocarbyl, and functional groups;
Q is an organic diradical;
X 1 and X 2 are anionic ligands, and may be the same or different;
L 1 is a neutral electron donor ligand, and p is zero or 1;
when α is a single bond, L 2 is selected from NR 7 R 8 , PR 7 R 8 , N═CR 7 R 8 , and R 7 C═NR 8 , where R 7 and R 8 are independently selected from substituted and/or heteroatom-containing C 1 -C 20 alkyl, C 2 -C 20 alkenyl, C 2 -C 20 alkynyl, and C 5 -C 24 aryl, or R 7 and R 8 can be taken together to form a heterocyclic ring;
when α is an unsaturated bond, L 2 is selected from NR 7 and PR 7 , where R 7 is as defined previously, or L 2 and Z represent adjacent atoms in an aromatic ring;
Y and Z are linkages independently selected from hydrocarbylene, substituted hydrocarbylene, heteroatom-containing hydrocarbylene, substituted heteroatom-containing hydrocarbylene, —O—, —S—, —NR 9 —, and —PR 9 —, wherein R 9 is selected from hydrocarbyl, substituted hydrocarbyl, heteroatom-containing hydrocarbyl, and substituted heteroatom-containing hydrocarbyl, and further wherein Y and Z may represent adjacent atoms in an aromatic ring;
m is zero or 1; and
n is zero or 1,
as well as isomers thereof.
8 . A complex having the structure of formula (II)
wherein:
β represent a single bond or an unsaturated bond;
M is a Group 8 transition metal;
R 1 and R 2 are independently selected from hydrogen, hydrocarbyl, substituted hydrocarbyl, heteroatom-containing hydrocarbyl, substituted heteroatom-containing hydrocarbyl, and functional groups;
Q is an organic diradical;
X 1 and X 2 are anionic ligands, and may be the same or different;
L 1 is a neutral electron donor ligand, and p is zero or 1;
R 7 and R 8 are independently selected from substituted and/or heteroatom-containing C 1 -C 20 alkyl, C 2 -C 20 alkenyl, C 2 -C 20 alkynyl, and C 5 -C 24 aryl, or R 7 and R 8 can be taken together to form a heterocyclic ring; and
Y and Z are linkages independently selected from hydrocarbylene, substituted hydrocarbylene, heteroatom-containing hydrocarbylene, substituted heteroatom-containing hydrocarbylene, —O—, —S—, —NR 9 —, and —PR 9 —, wherein R 9 is selected from hydrocarbyl, substituted hydrocarbyl, heteroatom-containing hydrocarbyl, and substituted heteroatom-containing hydrocarbyl, and further wherein Y and Z may represent adjacent atoms in an aromatic ring,
as well as isomers thereof.
9 . The complex of claim 8 , wherein R 7 and R 8 are C 1 -C 12 alkyl or C 5 -C 12 aryl, and Y is a substituted or unsubstituted methylene or ethylene linkage.
10 . A complex having the structure of formula (III)
wherein:
β represent a single bond or an unsaturated bond;
M is a Group 8 transition metal;
R 1 and R 2 are independently selected from hydrogen, hydrocarbyl, substituted hydrocarbyl, heteroatom-containing hydrocarbyl, substituted heteroatom-containing hydrocarbyl, and functional groups;
Q is an organic diradical;
X 1 and X 2 are anionic ligands, and may be the same or different;
L 1 is a neutral electron donor ligand, and p is zero or 1;
R 7 and R 8 are independently selected from substituted and/or heteroatom-containing C 1 -C 20 alkyl, C 2 -C 20 alkenyl, C 2 -C 20 alkynyl, and C 5 -C 24 aryl, or R 7 and R 8 can be taken together to form a heterocyclic ring; and
Y and Z are linkages independently selected from hydrocarbylene, substituted hydrocarbylene, heteroatom-containing hydrocarbylene, substituted heteroatom-containing hydrocarbylene, —O—, —S—, —NR 9 —, and —PR 9 —, wherein R 9 is selected from hydrocarbyl, substituted hydrocarbyl, heteroatom-containing hydrocarbyl, and substituted heteroatom-containing hydrocarbyl, and further wherein Y and Z may represent adjacent atoms in an aromatic ring,
as well as isomers thereof.
11 . The complex of claim 10 , wherein R 7 and R 8 are C 1 -C 12 alkyl or C 5 -C 12 aryl, and Y is a substituted or unsubstituted methylene or ethylene linkage.
12 . The complex of claim 11 , wherein R 7 and R 8 are phenyl and Y is ethylene.
13 . A complex having the structure of formula (IV)
wherein:
M is a Group 8 transition metal;
R 1 and R 2 are independently selected from hydrogen, hydrocarbyl, substituted hydrocarbyl, heteroatom-containing hydrocarbyl, substituted heteroatom-containing hydrocarbyl, and functional groups;
Q is an organic diradical;
X 1 and X 2 are anionic ligands, and may be the same or different;
L 1 is a neutral electron donor ligand, and p is zero or 1; and
Y is a linkage selected from hydrocarbylene, substituted hydrocarbylene, heteroatom-containing hydrocarbylene, substituted heteroatom-containing hydrocarbylene, —O—, —S—, —NR 9 —, and —PR 9 —, wherein R 9 is selected from hydrocarbyl, substituted hydrocarbyl, heteroatom-containing hydrocarbyl, and substituted heteroatom-containing hydrocarbyl,
as well as isomers thereof.
14 . A complex having the structure of formula (V)
wherein:
M is a Group 8 transition metal;
R 1 and R 2 are independently selected from hydrogen, hydrocarbyl, substituted hydrocarbyl, heteroatom-containing hydrocarbyl, substituted heteroatom-containing hydrocarbyl, and functional groups;
Q is an organic diradical;
X 1 and X 2 are anionic ligands, and may be the same or different;
L 1 is a neutral electron donor ligand, and p is zero or 1; and
R 7 is selected from substituted and/or heteroatom-containing C 1 -C 20 alkyl, C 2 -C 20 alkenyl, C 2 -C 20 alkynyl, and C 5 -C 24 aryl; and
Y and Z are linkages independently selected from hydrocarbylene, substituted hydrocarbylene, heteroatom-containing hydrocarbylene, substituted heteroatom-containing hydrocarbylene, —O—, —S—, —NR 9 —, and —PR 9 —, wherein R 9 is selected from hydrocarbyl, substituted hydrocarbyl, heteroatom-containing hydrocarbyl, and substituted heteroatom-containing hydrocarbyl,
as well as isomers thereof.
15 . A method for catalyzing an olefin metathesis reaction, comprising contacting an olefinic reactant with the catalytic complex of any one of claims 1 , 7 , 8 , 9 , 10 , 11 , 12 , 13 , or 14 under reaction conditions selected to enable olefin metathesis.Join the waitlist — get patent alerts
Track US2005261451A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.